Related Experiment Video
Updated: Jun 6, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
[Cryptococcal meningitis successfully treated with liposomal amphotericin B and voriconazole in an elderly patient]
Kotaro Ogaki1, Kazuyuki Noda, Jiro Fukae
1Department of Neurology, Juntendo University School of Medicine, Izunokuni-shi, Shizuoka, Japan.
Abstract:
Abstract An 81-year-old woman who had microscopic polyangiitis that was being treated with corticosteroids for 2 months was admitted to our department because of fever and clouding of consciousness. Neurological examination showed disturbance of consciousness and nuchal stiffness. Analysis of cerebrospinal fluid (CSF) revealed pleocytosis, low glucose level, and elevated protein levels. On the basis of the presence of Cryptococcus neoformans in CSF, the patient was diagnosed with cryptococcal meningitis. On the basis of established practice guidelines, liposomal amphotericin B (L-AMB) was administered to avoid the possible nephrotoxicity of amphotericin B. After the treatment was started, the patient's condition gradually improved. The results of CSF analysis also showed a gradual recovery. Because the cryptococcal antigen in CSF did not disappear completely, voriconazole (VRCZ) was administered orally; subsequently, the CSF cryptococcal antigen titer gradually decreased. During the course of the treatment with L-AMB and VRCZ, there were no severe side effects that required a change in treatment. To the best of our knowledge, in Japan, the combination of L-AMB and VRCZ has rarely been reported to be effective for the treatment of cryptococcal meningitis. The recovery of our patient indicates that the administration of L-AMB and VRCZ to elderly patients with cryptococcal meningitis and renal insufficiency is safe and leads to a successful outcome.
Insights
This study reports a successful treatment of cryptococcal meningitis in an elderly patient using liposomal amphotericin B (L-AMB) and voriconazole (VRCZ). The combination therapy proved safe and effective, even with co-existing renal insufficiency.
Area of Science:
- Infectious Diseases
- Neurology
- Pharmacology
Background:
- Cryptococcal meningitis is a serious opportunistic infection, particularly in immunocompromised individuals.
- Corticosteroid use for conditions like microscopic polyangiitis can increase the risk of fungal infections.
- Standard treatment guidelines aim to balance efficacy with minimizing drug-related toxicities, especially nephrotoxicity.
Observation:
- An 81-year-old woman on corticosteroids presented with fever and altered consciousness, indicative of meningitis.
- Cerebrospinal fluid analysis confirmed Cryptococcus neoformans infection, consistent with cryptococcal meningitis.
- Neurological examination revealed disturbed consciousness and nuchal rigidity.
Findings:
- Treatment with liposomal amphotericin B (L-AMB) led to clinical and cerebrospinal fluid (CSF) parameter improvements.
- Addition of voriconazole (VRCZ) was necessary due to persistent cryptococcal antigen in CSF, leading to a further decrease in antigen titers.
- The combined L-AMB and VRCZ regimen was well-tolerated, with no severe adverse events requiring treatment modification.
Implications:
- This case suggests that the combination of L-AMB and VRCZ is a safe and effective treatment option for cryptococcal meningitis in elderly patients, including those with renal insufficiency.
- The findings highlight a potentially valuable therapeutic strategy in a region where this specific combination has been rarely reported.
- Successful management underscores the importance of tailored antifungal therapy in immunocompromised elderly patients.
Related Concept Videos
Cryptococcal Meningitis
Antifungal Agents
Candidiasis
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Rocky Mountain Spotted Fever